Teva Pharmaceutical (TEVA)

Add to Watchlists Create an Alert
54.47 +0.07  +0.13% NYSE Jul 25, 8:00PM BATS Real time Currency in USD

Teva Pharmaceutical Return on Equity (TTM):

6.17% for March 31, 2014

View 4,000+ financial data types

View Full Chart

Teva Pharmaceutical Return on Equity (TTM) Chart

Export Data
Save Image

Teva Pharmaceutical Historical Return on Equity (TTM) Data

View and export this data going back to 1985. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
March 31, 2014 6.17%
Dec. 31, 2013 5.67%
Sept. 30, 2013 5.39%
June 30, 2013 1.86%
March 31, 2013 7.59%
Dec. 31, 2012 8.63%
Sept. 30, 2012 9.44%
June 30, 2012 13.72%
March 31, 2012 12.44%
Dec. 31, 2011 12.13%
Sept. 30, 2011 13.35%
June 30, 2011 14.39%
March 31, 2011 15.99%
Dec. 31, 2010 16.36%
Sept. 30, 2010 14.82%
June 30, 2010 13.32%
March 31, 2010 12.28%
Dec. 31, 2009 11.27%
Sept. 30, 2009 5.53%
June 30, 2009 5.74%
March 31, 2009 6.12%
Dec. 31, 2008 4.27%
Sept. 30, 2008 13.34%
June 30, 2008 13.06%
March 31, 2008 13.62%
   
Dec. 31, 2007 15.94%
Sept. 30, 2007 15.86%
June 30, 2007 17.46%
March 31, 2007 18.16%
Dec. 31, 2006 5.82%
Sept. 30, 2006 4.73%
June 30, 2006 0.71%
March 31, 2006 -3.12%
Dec. 31, 2005 19.42%
Sept. 30, 2005 19.62%
June 30, 2005 20.13%
March 31, 2005 20.73%
Dec. 31, 2004 7.35%
Sept. 30, 2004 6.11%
June 30, 2004 4.33%
March 31, 2004 4.42%
Dec. 31, 2003 29.55%
Sept. 30, 2003 31.89%
June 30, 2003 31.40%
March 31, 2003 27.23%
Dec. 31, 2002 26.00%
Sept. 30, 2002 23.94%
June 30, 2002 24.10%
March 31, 2002 23.51%
Dec. 31, 2001 22.16%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Return on Equity (ROE)

Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

Investors generally are interested in company's that have high, increasing returns on equity.
Learn More

Get data for
Advertisement

TEVA Return on Equity (TTM) Benchmarks

Companies
Mylan 20.91%
Pfizer 27.48%
Novartis 13.69%

TEVA Return on Equity (TTM) Range, Past 5 Years

Minimum 1.86% Jun 2013
Maximum 16.36% Dec 2010
Average 10.55%

TEVA Return on Equity (TTM) Excel Add-In Codes

  • Metric Code: return_on_equity
  • Latest data point: =YCP("TEVA", "return_on_equity")
  • Last 5 data points: =YCS("TEVA", "return_on_equity", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.